So much data and emails were turned over in a Risperdal lawsuit in Pennsylvania that the case was put on hold.
Emails quoted in the Risperdal lawsuit allege that there was a possible conflict of interest involved in a statistical analysis of Risperdal male breast growth data.
Lawyers for the plaintiff read emails between a statistician and an official who worked for Janssen Pharmaceuticals, the makers of Risperdal. Risperdal lawsuits have called into question the impartiality of research, arguing that Janssen may have exerted influence over research to try and hide the alleged link between Risperdal and male breast growth.
The legal team representing a man who allegedly suffered Risperdal male breast growth paints the relationship between Janssen and the researcher as friendly enough to compromise the data. The emails describe plans to met up for dinner and go to a Phillies game.
“They’re old hoagie buddies,” said the plaintiff’s lawyer.
The lawyer used the emails to contest Janssen Pharmaceutical’s argument that the company had a very limited role in the study. Plaintiff Timothy S., alleges that he developed Risperdal male breast growth.
The researcher in question was involved in a controversial reanalysis of data studying the possibility of Risperdal male breast growth. The data was first used in a 2003 medical article.
The Journal of Clinical Psychiatry originally published the article. Media reports and Risperdal lawsuits raised questions about the validity of the data and its interpretation, leading to a reanalysis. Janssen has insisted the company performed the reanalysis legitimately, and handed over the data to the FDA.
Janssen has handed over more than 30,000 documents totaling roughly 300,000 pages over the course of this Risperdal male breast growth lawsuit. So much data had been handed over, including the emails, that there is a three-week pause in the case to give the plaintiff’s legal team time to evaluate and digest the new documents.
Risperdal is a newer-generation antipsychotic drug, approved by the FDA to treat bipolar disorder, schizophrenia and related disorders, and some symptoms of autism. However, it has been alleged that Risperdal may increase the levels of prolactin in male patients, leading to male breast growth, or gynecomastia.
Prolactin is the hormone that normally helps direct breast growth in women. Some studies suggest that Risperal can increase prolactin levels. Additionally, Risperdal lawsuits have alleged that Janssen illegally marketed Risperdal by promoting the drug for off-label use. This means that Jansen allegedly tried to market Risperdal for uses other than those tested and approved under FDA rules.
The Risperdal lawsuit is the first in a series of coordinated Risperdal male breast growth lawsuits with a single MDL. An MDL, or multidistrict litigation, is a process the legal system uses to coordinate cases together.
Since Risperdal lawsuits make similar allegations of Risperdal male breast growth and hinge on similar evidence, they were grouped together into a Risperdal MDL. The first cases in an MDL, called bellwether cases, are used to establish precedents that can apply to the rest of the Risperdal lawsuits in the MDL.
The Risperdal lawsuit involving Timothy S. is a bellwether case, and as such, it is being watched closely. The outcome of this Risperdal lawsuit could ultimately determine the fate of hundreds, if not thousands, of other Risperdal lawsuits. A ruling is expected this month.
The Risperdal Lawsuit is filed within the larger Risperdal MDL: In RE: Risperdal Litigation, Case No. 100300296, filed in the Philadelphia Court of Common Pleas.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Risperdal attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Risperdal class action lawsuit is best for you. [In general, Risperdal lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2016 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Risperdal Class Action Lawsuit Investigation
If you or your son took Risperdal between the ages of 10 and 18 years old and suffered gynecomastia (male breast growth), male breast pain, nipple pain, or nipple discharge, you may be entitled to compensation. See if you qualify by submitting your information below for a free and confidential case review.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- If you're filling this out for a loved one, what is the name of the person who took Risperdal?*
- Are you/your loved one a male who took Risperdal between the ages of 10 and 18 years old?*
YesNo
- What year was the person who took Risperdal born?*
- How old was this person when they took Risperdal?*
- Please check the Risperdal injuries suffered:*
-
Breast Growth
-
Breast Pain
-
Nipple Pain
-
Nipple Discharge
-
- How old were you/your loved one when these problems began?*
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 25) {gformInitChosenFields(‘#input_25_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_25_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_25_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [25, 1]) } );
The post Risperdal Male Breast Growth Lawsuit Resumes appeared first on Top Class Actions.
No comments:
Post a Comment